The association between severity of HCV-induced liver damage and apoE genotype was also examined revealing significantly lower ε4 allele frequencies in patients with severe versus mild inflammation and fibrosis [48] and a reduced risk of viral persistence [53] and chronic infection [59] in apoE4 carriers, suggesting that apoE4 protects HCV infected patients from developing severe liver disease. This evidence concerns the gene APOE and liver disorder.